Literature DB >> 20683941

Involvement of PA28gamma in the propagation of hepatitis C virus.

Kohji Moriishi1, Ikuo Shoji, Yoshio Mori, Ryosuke Suzuki, Tetsuro Suzuki, Chikako Kataoka, Yoshiharu Matsuura.   

Abstract

UNLABELLED: We have reported previously that the proteasome activator PA28gamma participates not only in degradation of hepatitis C virus (HCV) core protein in the nucleus but also in the pathogenesis in transgenic mice expressing HCV core protein. However, the biological significance of PA28gamma in the propagation of HCV has not been clarified. PA28gamma is an activator of proteasome responsible for ubiquitin-independent degradation of substrates in the nucleus. In the present study, knockdown of PA28gamma in cells preinfection or postinfection with the JFH-1 strain of HCV impaired viral particle production but exhibited no effect on viral RNA replication. The particle production of HCV in PA28gamma knockdown cells was restored by the expression of an small interfering RNA (siRNA)-resistant PA28gamma. Although viral proteins were detected in the cytoplasm of cells infected with HCV, suppression of PA28gamma expression induced accumulation of HCV core protein in the nucleus. HCV core protein was also degraded in the cytoplasm after ubiquitination by an E3 ubiquitin ligase, E6AP. Knockdown of PA28gamma enhanced ubiquitination of core protein and impaired virus production, whereas that of E6AP reduced ubiquitination of core protein and enhanced virus production. Furthermore, virus production in the PA28gamma knockdown cells was restored through knockdown of E6AP or expression of the siRNA-resistant wild-type but not mutant PA28gamma incapable of activating proteasome activity.
CONCLUSION: Our results suggest that PA28gamma participates not only in the pathogenesis but also in the propagation of HCV by regulating the degradation of the core protein in both a ubiquitin-dependent and ubiquitin-independent manner.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683941     DOI: 10.1002/hep.23680

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  24 in total

1.  Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Authors:  Takasuke Fukuhara; Hiroto Kambara; Mai Shiokawa; Chikako Ono; Hiroshi Katoh; Eiji Morita; Daisuke Okuzaki; Yoshihiko Maehara; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Roles of the two distinct proteasome pathways in hepatitis C virus infection.

Authors:  Ikuo Shoji
Journal:  World J Virol       Date:  2012-04-12

3.  Characterization of Recombinant Flaviviridae Viruses Possessing a Small Reporter Tag.

Authors:  Tomokazu Tamura; Takasuke Fukuhara; Takuro Uchida; Chikako Ono; Hiroyuki Mori; Asuka Sato; Yuzy Fauzyah; Toru Okamoto; Takeshi Kurosu; Yin Xiang Setoh; Michio Imamura; Norbert Tautz; Yoshihiro Sakoda; Alexander A Khromykh; Kazuaki Chayama; Yoshiharu Matsuura
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

4.  Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122.

Authors:  Hiroto Kambara; Takasuke Fukuhara; Mai Shiokawa; Chikako Ono; Yuri Ohara; Wataru Kamitani; Yoshiharu Matsuura
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

5.  Involvement of the nuclear proteasome activator PA28γ in the cellular response to DNA double-strand breaks.

Authors:  Adva Levy-Barda; Yaniv Lerenthal; Anthony J Davis; Young Min Chung; Jeroen Essers; Zhengping Shao; Nicole van Vliet; David J Chen; Mickey C-T Hu; Roland Kanaar; Yael Ziv; Yosef Shiloh
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

6.  High expression of REGγ is associated with metastasis and poor prognosis of patients with breast cancer.

Authors:  Fan Chai; Yan Liang; Jiong Bi; Li Chen; Fan Zhang; Youhong Cui; Xiuwu Bian; Jun Jiang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

7.  HCV core inhibits hepatocellular carcinoma cell replicative senescence through downregulating microRNA-138 expression.

Authors:  Tzu-Yue Shiu; Yu-Lueng Shih; An-Chieh Feng; Hsuan-Hwai Lin; Shih-Ming Huang; Tien-Yu Huang; Chung-Bao Hsieh; Wei-Kuo Chang; Tsai-Yuan Hsieh
Journal:  J Mol Med (Berl)       Date:  2017-03-03       Impact factor: 4.599

8.  Novel permissive cell lines for complete propagation of hepatitis C virus.

Authors:  Mai Shiokawa; Takasuke Fukuhara; Chikako Ono; Satomi Yamamoto; Toru Okamoto; Noriyuki Watanabe; Takaji Wakita; Yoshiharu Matsuura
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

Review 9.  Post-translational modifications of hepatitis C viral proteins and their biological significance.

Authors:  Jana Hundt; Zhubing Li; Qiang Liu
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

10.  Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp.

Authors:  Yuusuke Fujimoto; Kazi Abdus Salam; Atsushi Furuta; Yasuyoshi Matsuda; Osamu Fujita; Hidenori Tani; Masanori Ikeda; Nobuyuki Kato; Naoya Sakamoto; Shinya Maekawa; Nobuyuki Enomoto; Nicole J de Voogd; Masamichi Nakakoshi; Masayoshi Tsubuki; Yuji Sekiguchi; Satoshi Tsuneda; Nobuyoshi Akimitsu; Naohiro Noda; Atsuya Yamashita; Junichi Tanaka; Kohji Moriishi
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.